Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

COVID-19 3Hematologic Neoplasms 2Chronic Disease 1

Interventions

Surveys and Questionnaires 3BNT162 Vaccine 3Surgical Procedures, Operative 2sinovac COVID-19 vaccine 1Serologic Tests 1Prednisone 1Molecular Diagnostic Techniques 1Methylprednisolone 1Medical Marijuana 1Magnetic Resonance Spectroscopy 1Hydroxychloroquine 1High-Throughput Nucleotide Sequencing 1Glucocorticoids 1Drug Therapy 1Dexamethasone 1Data Collection 1CVnCoV COVID-19 vaccine 1COVID-19 Vaccines 1COVID-19 Serotherapy 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × COVID-19 × BNT162 Vaccine × Clear all
NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

University of Liege

Phase 3 Unknown
50 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04743388 2022-04-11

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

National and Kapodistrian University of Athens

Unknown
600 enrolled
Other hematologic neoplasm

COVID-19, Chronic Disease, Hematologic Neoplasms

NCT05119738 2022-02-02

Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

Pontificia Universidad Catolica de Chile

Unknown
122 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡